<p>Cyndeo Wealth Partners LLC 在最近向證券交易委員會提交的文件中表示，在第三季度減少了對 HCA Healthcare, Inc. (NYSE:HCA - 免費報告) 的持股比例，降幅為 58.7%。該公司在此期間出售了 14,376 股後，持有 10,099 股 HCA 的股票。Cyndeo Wealth Partners LLC 在 HCA Healthcare 的持股在最近的報告期末價值為 4,304,000 美元。</p>
<ul>
<li>MarketBeat 週迴顧 – 07/28 - 08/01</li>
</ul>
<p>其他一些大型投資者也對 HCA 的持倉進行了調整。Brighton Jones LLC 在第四季度購買了 HCA Healthcare 的新頭寸，價值約為 1,021,000 美元。T. Rowe Price Investment Management Inc. 在第一季度將其在 HCA Healthcare 的持倉提高了 13.1%。T. Rowe Price Investment Management Inc. 現在擁有 2,546 股該公司的股票，價值 880,000 美元，此前在此期間又購買了 295 股。CW Advisors LLC 在第一季度將其在 HCA Healthcare 的持股增加了 22.9%。CW Advisors LLC 現在擁有 1,277 股該公司的股票，價值 441,000 美元，此前在上個季度又收購了 238 股。Norinchukin Bank The 在第一季度將其在 HCA Healthcare 的持倉提高了 10.7%。Norinchukin Bank The 現在擁有 7,966 股該公司的股票，價值 2,753,000 美元，此前在上個季度又購買了 770 股。最後，Ameriprise Financial Inc. 在第一季度將其在 HCA Healthcare 的持股增加了 10.2%。Ameriprise Financial Inc. 現在擁有 483,564 股該公司的股票，價值 167,094,000 美元，此前在此期間又購買了 44,884 股。機構投資者和對沖基金持有該公司 62.73% 的股票。</p>
<p>獲取 <strong>HCA Healthcare</strong> 警報：</p>
<h2>HCA Healthcare 股價上漲 1.3%</h2>
<p>HCA Healthcare 股票週五開盤價為 472.69 美元。該公司的市值為 1,078.7 億美元，市盈率為 18.27，PEG 比率為 1.40，貝塔值為 1.36。HCA Healthcare, Inc. 的一年低點為 289.98 美元，一年高點為 520.00 美元。該公司的 50 日簡單移動平均線為 470.12 美元，200 日簡單移動平均線為 417.03 美元。</p>
<ul>
<li>HCA Healthcare 能否振興市場最疲軟的行業？</li>
</ul>
<p>HCA Healthcare (NYSE:HCA - 獲取免費報告) 最近於 10 月 24 日發佈了季度財報。公司報告本季度每股收益 (EPS) 為 6.96 美元，超出分析師一致預期的 5.64 美元，超出幅度為 1.32 美元。HCA Healthcare 的淨利潤率為 8.53%，股本回報率為 -792.25%。公司本季度的收入為 191.6 億美元，而分析師預期為 185.5 億美元。在去年同期，公司每股收益為 4.90 美元。與去年同期相比，公司的季度收入增長了 9.6%。HCA Healthcare 已設定 2025 財年的每股收益指導範圍為 27.000-28.000。整體來看，研究分析師預測 HCA Healthcare, Inc. 本年度每股收益將為 24.98 美元。</p>
<h2>HCA Healthcare 分紅公告</h2>
<p>該公司最近還披露了季度分紅，將於 12 月 29 日星期一支付。12 月 15 日的股東將獲得 0.72 美元的分紅。這代表着年化分紅為 2.88 美元，分紅收益率為 0.6%。該分紅的除息日期為 12 月 15 日星期一。HCA Healthcare 的分紅支付比率目前為 11.13%。</p>
<h2>分析師評級上調與下調</h2>
<ul>
<li>綜合醫療股票能否在公開市場上成功？</li>
</ul>
<p>幾位股票分析師最近對該股票發表了評論。Jefferies Financial Group 將 HCA Healthcare 的目標價從 485.00 美元上調至 525.00 美元，並在 10 月 28 日的報告中給予該公司 &#34;買入&#34; 評級。Cowen 在 10 月 27 日的研究報告中重申了對 HCA Healthcare 的 &#34;買入&#34; 評級。Zacks Research 在 11 月 27 日的研究報告中將 HCA Healthcare 的評級從 &#34;強力買入&#34; 下調至 &#34;持有&#34;。加拿大皇家銀行在週五的研究報告中將 HCA Healthcare 的目標價從 482.00 美元上調至 525.00 美元，並給予該公司 &#34;跑贏大盤&#34; 的評級。最後，瑞銀集團在 10 月 27 日的報告中將 HCA Healthcare 的目標價從 495.00 美元上調至 525.00 美元，並給予該公司 &#34;買入&#34; 評級。十四位研究分析師對該股票給予了買入評級，九位給予了持有評級，一位給予了賣出評級。根據 MarketBeat 的數據，該股票目前的平均評級為 &#34;適度買入&#34;，平均目標價為 479.00 美元。</p>
<p><strong>閲讀我們關於 HCA 的最新報告</strong></p>
<h2>HCA Healthcare 的內部交易</h2>
<p>在相關消息中，執行副總裁 Michael R. Mcalevey 於 11 月 5 日星期三出售了 3,892 股該公司的股票。股票以平均價格 473.79 美元出售，總交易額為 1,843,990.68 美元。交易完成後，該執行副總裁直接持有該公司 3,487 股股票，價值 1,652,105.73 美元。這代表着其持股比例減少了 52.74%。該交易已在向證券交易委員會提交的文件中披露，相關文件可通過此鏈接獲取。公司內部人士持有該公司 1.30% 的股票。</p>
<h2>關於 HCA Healthcare</h2>
<p>(免費報告)</p>
<p>HCA Healthcare 是一家以盈利為目的的醫療設施運營商，總部位於田納西州納什維爾。公司成立於 1968 年，擁有並運營一系列醫院及相關醫療設施，並通過有機擴張和收購發展成為大型住院和門診服務提供商。</p>
<p>公司的核心業務包括急救醫院、獨立外科和急救中心以及門診診所的運營。HCA 的服務涵蓋住院護理、外科服務、急救醫學、診斷影像和實驗室檢測，以及各種門診和流動護理服務。</p>
<h2>推薦故事</h2>
<ul>
<li>五隻我們認為比 HCA Healthcare 更好的股票</li>
<li>高分紅房地產投資信託：它們是理想的多元化方式嗎？</li>
<li>這三家銀行在年末反彈，但這種趨勢會持續嗎？</li>
<li>通過這些分紅之王渡過衰退</li>
<li>三隻飆升的股票剛剛獲得標準普爾 500 的最終認可</li>
<li>稀釋每股收益（Diluted EPS）是什麼？</li>
<li>這隻 ETF 在美聯儲降息後獲得了重大順風</li>
</ul>
<p><strong>想看看其他對 HCA 持有的對沖基金嗎？</strong> 請訪問 HoldingsChannel.com，獲取 HCA Healthcare, Inc.（NYSE:HCA - 免費報告）的最新 13F 文件和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在 HCA Healthcare 嗎？</h2>
<p>在考慮 HCA Healthcare 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 HCA Healthcare 並不在名單上。</p>
<p>雖然 HCA Healthcare 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

HCA控股

<p>Cyndeo Wealth Partners LLC 在第三季度減少了對 HCA Healthcare 的持股比例，降幅為 58.7%，目前持有 10,099 股，價值 430 萬美元。HCA 的股票開盤價為 472.69 美元，市值為 1078.7 億美元。該公司報告第三季度每股收益為 6.96 美元，超出預期，並宣佈每季度派息 0.72 美元。分析師的評級意見不一，大多數分析師推薦買入</p>

<p>Cyndeo Wealth Partners LLC lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 58.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 10,099 shares of the company's stock after selling 14,376 shares during the period. Cyndeo Wealth Partners LLC's holdings in HCA Healthcare were worth $4,304,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Cyndeo Wealth Partners LLC 在最近向證券交易委員會提交的文件中表示，在第三季度減少了對 HCA Healthcare, Inc. (NYSE:HCA - 免費報告) 的持股比例，降幅為 58.7%。該公司在此期間出售了 14,376 股後，持有 10,099 股 HCA 的股票。Cyndeo Wealth Partners LLC 在 HCA Healthcare 的持股在最近的報告期末價值為 4,304,000 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 07/28 - 08/01</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧 – 07/28 - 08/01</li>
</ul>
</div><p>A number of other large investors have also made changes to their positions in HCA. Brighton Jones LLC purchased a new position in HCA Healthcare during the 4th quarter worth approximately $1,021,000. T. Rowe Price Investment Management Inc. raised its position in HCA Healthcare by 13.1% during the first quarter. T. Rowe Price Investment Management Inc. now owns 2,546 shares of the company's stock valued at $880,000 after buying an additional 295 shares during the period. CW Advisors LLC grew its stake in HCA Healthcare by 22.9% during the 1st quarter. CW Advisors LLC now owns 1,277 shares of the company's stock valued at $441,000 after acquiring an additional 238 shares in the last quarter. Norinchukin Bank The lifted its position in shares of HCA Healthcare by 10.7% in the first quarter. Norinchukin Bank The now owns 7,966 shares of the company's stock worth $2,753,000 after purchasing an additional 770 shares in the last quarter. Finally, Ameriprise Financial Inc. increased its stake in HCA Healthcare by 10.2% in the 1st quarter. Ameriprise Financial Inc. now owns 483,564 shares of the company's stock valued at $167,094,000 after buying an additional 44,884 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.</p>
<div class="lb-trans"><p>其他一些大型投資者也對 HCA 的持倉進行了調整。Brighton Jones LLC 在第四季度購買了 HCA Healthcare 的新頭寸，價值約為 1,021,000 美元。T. Rowe Price Investment Management Inc. 在第一季度將其在 HCA Healthcare 的持倉提高了 13.1%。T. Rowe Price Investment Management Inc. 現在擁有 2,546 股該公司的股票，價值 880,000 美元，此前在此期間又購買了 295 股。CW Advisors LLC 在第一季度將其在 HCA Healthcare 的持股增加了 22.9%。CW Advisors LLC 現在擁有 1,277 股該公司的股票，價值 441,000 美元，此前在上個季度又收購了 238 股。Norinchukin Bank The 在第一季度將其在 HCA Healthcare 的持倉提高了 10.7%。Norinchukin Bank The 現在擁有 7,966 股該公司的股票，價值 2,753,000 美元，此前在上個季度又購買了 770 股。最後，Ameriprise Financial Inc. 在第一季度將其在 HCA Healthcare 的持股增加了 10.2%。Ameriprise Financial Inc. 現在擁有 483,564 股該公司的股票，價值 167,094,000 美元，此前在此期間又購買了 44,884 股。機構投資者和對沖基金持有該公司 62.73% 的股票。</p>
</div><p>Get <strong>HCA Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>HCA Healthcare</strong> 警報：</p>
</div><h2>HCA Healthcare Trading Up 1.3%</h2>
<div class="lb-trans"><h2>HCA Healthcare 股價上漲 1.3%</h2>
</div><p>Shares of HCA Healthcare stock opened at $472.69 on Friday. The stock has a market capitalization of $107.87 billion, a price-to-earnings ratio of 18.27, a PEG ratio of 1.40 and a beta of 1.36. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $520.00. The firm has a fifty day simple moving average of $470.12 and a 200-day simple moving average of $417.03.</p>
<div class="lb-trans"><p>HCA Healthcare 股票週五開盤價為 472.69 美元。該公司的市值為 1,078.7 億美元，市盈率為 18.27，PEG 比率為 1.40，貝塔值為 1.36。HCA Healthcare, Inc. 的一年低點為 289.98 美元，一年高點為 520.00 美元。該公司的 50 日簡單移動平均線為 470.12 美元，200 日簡單移動平均線為 417.03 美元。</p>
</div><ul>
<li>Can HCA Healthcare Revive the Market’s Weakest Sector?</li>
</ul>
<div class="lb-trans"><ul>
<li>HCA Healthcare 能否振興市場最疲軟的行業？</li>
</ul>
</div><p>HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company had revenue of $19.16 billion during the quarter, compared to analysts' expectations of $18.55 billion. During the same period in the prior year, the company earned $4.90 earnings per share. The business's quarterly revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.</p>
<div class="lb-trans"><p>HCA Healthcare (NYSE:HCA - 獲取免費報告) 最近於 10 月 24 日發佈了季度財報。公司報告本季度每股收益 (EPS) 為 6.96 美元，超出分析師一致預期的 5.64 美元，超出幅度為 1.32 美元。HCA Healthcare 的淨利潤率為 8.53%，股本回報率為 -792.25%。公司本季度的收入為 191.6 億美元，而分析師預期為 185.5 億美元。在去年同期，公司每股收益為 4.90 美元。與去年同期相比，公司的季度收入增長了 9.6%。HCA Healthcare 已設定 2025 財年的每股收益指導範圍為 27.000-28.000。整體來看，研究分析師預測 HCA Healthcare, Inc. 本年度每股收益將為 24.98 美元。</p>
</div><h2>HCA Healthcare Dividend Announcement</h2>
<div class="lb-trans"><h2>HCA Healthcare 分紅公告</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare's dividend payout ratio is currently 11.13%.</p>
<div class="lb-trans"><p>該公司最近還披露了季度分紅，將於 12 月 29 日星期一支付。12 月 15 日的股東將獲得 0.72 美元的分紅。這代表着年化分紅為 2.88 美元，分紅收益率為 0.6%。該分紅的除息日期為 12 月 15 日星期一。HCA Healthcare 的分紅支付比率目前為 11.13%。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級上調與下調</h2>
</div><ul>
<li>Can Integrated Healthcare Stocks Succeed in Public Markets?</li>
</ul>
<div class="lb-trans"><ul>
<li>綜合醫療股票能否在公開市場上成功？</li>
</ul>
</div><p>Several equities analysts have recently commented on the stock. Jefferies Financial Group boosted their price target on shares of HCA Healthcare from $485.00 to $525.00 and gave the company a &#34;buy&#34; rating in a report on Tuesday, October 28th. Cowen reaffirmed a &#34;buy&#34; rating on shares of HCA Healthcare in a research report on Monday, October 27th. Zacks Research cut HCA Healthcare from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Thursday, November 27th. Royal Bank Of Canada lifted their target price on shares of HCA Healthcare from $482.00 to $525.00 and gave the company an &#34;outperform&#34; rating in a research note on Friday. Finally, UBS Group raised their price target on shares of HCA Healthcare from $495.00 to $525.00 and gave the company a &#34;buy&#34; rating in a report on Monday, October 27th. Fourteen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of &#34;Moderate Buy&#34; and an average target price of $479.00.</p>
<div class="lb-trans"><p>幾位股票分析師最近對該股票發表了評論。Jefferies Financial Group 將 HCA Healthcare 的目標價從 485.00 美元上調至 525.00 美元，並在 10 月 28 日的報告中給予該公司 &#34;買入&#34; 評級。Cowen 在 10 月 27 日的研究報告中重申了對 HCA Healthcare 的 &#34;買入&#34; 評級。Zacks Research 在 11 月 27 日的研究報告中將 HCA Healthcare 的評級從 &#34;強力買入&#34; 下調至 &#34;持有&#34;。加拿大皇家銀行在週五的研究報告中將 HCA Healthcare 的目標價從 482.00 美元上調至 525.00 美元，並給予該公司 &#34;跑贏大盤&#34; 的評級。最後，瑞銀集團在 10 月 27 日的報告中將 HCA Healthcare 的目標價從 495.00 美元上調至 525.00 美元，並給予該公司 &#34;買入&#34; 評級。十四位研究分析師對該股票給予了買入評級，九位給予了持有評級，一位給予了賣出評級。根據 MarketBeat 的數據，該股票目前的平均評級為 &#34;適度買入&#34;，平均目標價為 479.00 美元。</p>
</div><p><strong>Read Our Latest Report on HCA</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 HCA 的最新報告</strong></p>
</div><h2>Insider Transactions at HCA Healthcare</h2>
<div class="lb-trans"><h2>HCA Healthcare 的內部交易</h2>
</div><p>In related news, EVP Michael R. Mcalevey sold 3,892 shares of the company's stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This represents a 52.74% decrease in their position. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through this link. Company insiders own 1.30% of the company's stock.</p>
<div class="lb-trans"><p>在相關消息中，執行副總裁 Michael R. Mcalevey 於 11 月 5 日星期三出售了 3,892 股該公司的股票。股票以平均價格 473.79 美元出售，總交易額為 1,843,990.68 美元。交易完成後，該執行副總裁直接持有該公司 3,487 股股票，價值 1,652,105.73 美元。這代表着其持股比例減少了 52.74%。該交易已在向證券交易委員會提交的文件中披露，相關文件可通過此鏈接獲取。公司內部人士持有該公司 1.30% 的股票。</p>
</div><h2>About HCA Healthcare</h2>
<div class="lb-trans"><h2>關於 HCA Healthcare</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.</p>
<div class="lb-trans"><p>HCA Healthcare 是一家以盈利為目的的醫療設施運營商，總部位於田納西州納什維爾。公司成立於 1968 年，擁有並運營一系列醫院及相關醫療設施，並通過有機擴張和收購發展成為大型住院和門診服務提供商。</p>
</div><p>The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.</p>
<div class="lb-trans"><p>公司的核心業務包括急救醫院、獨立外科和急救中心以及門診診所的運營。HCA 的服務涵蓋住院護理、外科服務、急救醫學、診斷影像和實驗室檢測，以及各種門診和流動護理服務。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than HCA Healthcare</li>
<li>High Dividend REITs: Are They an Ideal Way to Diversify?</li>
<li>These 3 Banks Are Rallying Into Year-End, But Will It Continue?</li>
<li>Ride Out The Recession With These Dividend Kings</li>
<li>3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&amp;P 500</li>
<li>What is diluted earnings per share (Diluted EPS)?</li>
<li>This ETF Caught a Major Tailwind After the Fed’s Rate Cut</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比 HCA Healthcare 更好的股票</li>
<li>高分紅房地產投資信託：它們是理想的多元化方式嗎？</li>
<li>這三家銀行在年末反彈，但這種趨勢會持續嗎？</li>
<li>通過這些分紅之王渡過衰退</li>
<li>三隻飆升的股票剛剛獲得標準普爾 500 的最終認可</li>
<li>稀釋每股收益（Diluted EPS）是什麼？</li>
<li>這隻 ETF 在美聯儲降息後獲得了重大順風</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding HCA?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對 HCA 持有的對沖基金嗎？</strong> 請訪問 HoldingsChannel.com，獲取 HCA Healthcare, Inc.（NYSE:HCA - 免費報告）的最新 13F 文件和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=HCA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in HCA Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 HCA Healthcare 嗎？</h2>
</div><p>Before you consider HCA Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 HCA Healthcare 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 HCA Healthcare 並不在名單上。</p>
</div><p>While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 HCA Healthcare 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Cyndeo Wealth Partners LLC 在 HCA Healthcare, Inc.持有價值 430 萬美元的股票頭寸